Bolton LP’s CorMedix CRMD Stock Holding History

Bolton LP’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,240	Closed	-$102K	–	137
2015 Q2	$102K	Buy	+5,240	New	+$180K	0.03%	165

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Bolton LP's CRMD Position: Q3 2015 in Review

Bolton LP sold out of CorMedix (CRMD) in Q3 2015, closing a stake of 5,240 shares — an estimated $102K sold.

Bolton LP first reported a position in CRMD in Q2 2015 and held it in 1 quarter. The position peaked at $102K in Q2 2015. 54 funds tracked by Wall St. Rank hold CRMD as of Q3 2015.

Bolton LP reported no remaining CorMedix position as of Q3 2015 after selling out during the quarter.
Bolton LP sold 5,240 CorMedix shares in Q3 2015, an estimated $102K.
Bolton LP first reported a position in CorMedix in Q2 2015 and held it in 1 quarter.
Bolton LP's CorMedix position peaked at $102K in Q2 2015.
54 funds tracked by Wall St. Rank held CorMedix as of Q3 2015.

Based on Bolton LP's 13F filing for Q3 2015, filed 16 Nov 2015.